Activation pathways that drive CD4 + T cells to break tolerance in autoimmune diseases .
Sai Harsha KroviVijay K KuchrooPublished in: Immunological reviews (2022)
Autoimmune diseases are characterized by dysfunctional immune systems that misrecognize self as non-self and cause tissue destruction. Several cell types have been implicated in triggering and sustaining disease. Due to a strong association of major histocompatibility complex II (MHC-II) proteins with various autoimmune diseases, CD4 + T lymphocytes have been thoroughly investigated for their roles in dictating disease course. CD4 + T cell activation is a coordinated process that requires three distinct signals: Signal 1, which is mediated by antigen recognition on MHC-II molecules; Signal 2, which boosts signal 1 in a costimulatory manner; and Signal 3, which helps to differentiate the activated cells into functionally relevant subsets. These signals are disrupted during autoimmunity and prompt CD4 + T cells to break tolerance. Herein, we review our current understanding of how each of the three signals plays a role in three different autoimmune diseases and highlight the genetic polymorphisms that predispose individuals to autoimmunity. We also discuss the drawbacks of existing therapies and how they can be addressed to achieve lasting tolerance in patients.
Keyphrases
- end stage renal disease
- ejection fraction
- induced apoptosis
- newly diagnosed
- chronic kidney disease
- prognostic factors
- cell cycle arrest
- mesenchymal stem cells
- signaling pathway
- stem cells
- peripheral blood
- mass spectrometry
- patient reported outcomes
- endoplasmic reticulum stress
- cell proliferation
- cell death
- celiac disease
- functional connectivity
- resting state
- pi k akt